Top Markets
#1 Pleasing Gold Pleasing Gold +1,497.26%
#2 PulseChain PulseChain +58.12%
#3 Merlin's Seal BTC Merlin's Seal BTC +33.63%
#4 Ontology Gas Ontology Gas +33.04%
#5 BOOK OF MEME BOOK OF MEME +29.03%
#6 ConstitutionDAO ConstitutionDAO +27.43%
#7 Collect on Fanable Collect on Fanable +24.55%
#8 Unit Pump Unit Pump +21.78%
#9 Pump.fun Pump.fun +21.78%
#10 Nockchain Nockchain +21.45%
Coin of the day
Pleasing Gold Pleasing Gold
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
NeoCore Technology Co., Ltd. NeoCore Technology Co., Ltd.

NeoCore Technology Co., Ltd.

4131
Classifica tra le azioni #26461
NeoCore Technology Co., Ltd. is primarily engaged in the creation, manufacture,... NeoCore Technology Co., Ltd. is primarily engaged in the creation, manufacture, and distribution of biochips and advanced rapid nucleic acid hybridization devices. Their extensive product range features systems designed for food safety screening, human diagnostic arrays, agricultural analysis, and specific food examination arrays, in addition to a variety of laboratory instruments and DNA kits. The company further provides a suite of services, encompassing laboratory planning, design, and additional specialized support. Beyond its core biotech operations, NeoCore also participates in the wholesale and retail market for contact lenses. The firm, which was established in 1987 and is based in Tainan, Taiwan, underwent a name change in July 2023, transitioning from its former identity as DR. Chip Biotechnology Incorporation to its current name.
Prezzo delle azioni
$1.02
Capitalizzazione di mercato
$40.42M
Variazione (1 giorno)
-1.08%
Variazione (1 anno)
-10.53%
Paese
TW
Scambia NeoCore Technology Co., Ltd. (4131)

Categoria

Healthcare
Utile per NeoCore Technology Co., Ltd. (4131)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di NeoCore Technology Co., Ltd., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di NeoCore Technology Co., Ltd. dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US